UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

Neurology, 2011-09, Vol.77 (13), p.1253-1262

2011

Volltextzugriff (PDF)

NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients

Neurology, 2005-09, Vol.65 (5), p.681-689

2005

Volltextzugriff (PDF)

An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema

British journal of ophthalmology, 2009-02, Vol.93 (2), p.144-149

2009

Volltextzugriff (PDF)

Seeing with new eyes: Finding a path to early intervention trials in Alzheimer’s disease

The Journal of nutrition, health & aging, 2010-04, Vol.14 (4), p.306-309

2010

Volltextzugriff (PDF)

Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials

Journal of the neurological sciences, 1997-10, Vol.152, p.s1-s9

1997

Volltextzugriff (PDF)

Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans

Gastroenterology (New York, N.Y. 1943), 2000-07, Vol.119 (1), p.41-50

2000

Volltextzugriff (PDF)

Arrest of Motor Neuron Disease in wobbler Mice Cotreated with CNTF and BDNF

Science (American Association for the Advancement of Science), 1994-08, Vol.265 (5175), p.1107-1110

1994

Volltextzugriff (PDF)

Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat

Annals of neurology, 1998-01, Vol.43 (1), p.46-55

1998

Volltextzugriff (PDF)

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function

Journal of the neurological sciences, 1999-10, Vol.169 (1), p.13-21

1999

Volltextzugriff (PDF)

A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials

Journal of the neurological sciences, 1999-10, Vol.169 (1), p.118-125

1999

Volltextzugriff (PDF)

Sarcopenia: Biomarkers and imaging (International Conference on Sarcopenia research)

The Journal of nutrition, health & aging, 2011-12, Vol.15 (10), p.834-846

2011

Volltextzugriff (PDF)

NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients

Neurology, 2005-09, Vol.65 (5), p.681

2005

Volltextzugriff (PDF)

Trial of Cinpanemab in Early Parkinson’s Disease

The New England journal of medicine, 2022-08, Vol.387 (5), p.408-420

2022

Volltextzugriff (PDF)

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Movement disorders, 2020-11, Vol.35 (11), p.1999-2008

2020

Volltextzugriff (PDF)

Endogenous NGF and CNTF levels in human peripheral nerve injury

Neuroreport, 1997-05, Vol.8 (8), p.1935-1938

1997

Volltextzugriff (PDF)

Prognostic indicators of survival in ALS

Neurology, 1998-01, Vol.50 (1), p.66-72

1998

Volltextzugriff (PDF)

Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

Annals of neurology, 1995-04, Vol.37 (4), p.505-511

1995

Volltextzugriff (PDF)

The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

Annals of neurology, 1994-08, Vol.36 (2), p.142-148

1994

Volltextzugriff (PDF)

The Therapeutic Potential of Neurotrophic Factors in the Treatment of Parkinson's Disease

Experimental neurology, 1993-11, Vol.124 (1), p.103-118

1993

Volltextzugriff (PDF)

Clinical pharmacokinetics of anti-Parkinsonian drugs

Clinical pharmacokinetics, 1987-09, Vol.13 (3), p.141-178

CEDARBAUM, J. M

1987

Volltextzugriff (PDF)

Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease

Annals of neurology, 1991-05, Vol.29 (5), p.556-559

1991

Volltextzugriff (PDF)

"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease

Neurology, 1991-05, Vol.41 (5), p.622-629

1991

Volltextzugriff (PDF)

Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease

Nature medicine, 1995-02, Vol.1 (2), p.168-172

1995

Volltextzugriff (PDF)

A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis

Neurology, 1996-05, Vol.46 (5), p.1244-1244

ALS CNTF Treatment Study Group

1996

Volltextzugriff (PDF)

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa

Movement disorders, 1993, Vol.8 (3), p.298-304

1993

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(124)
Buchkapitel
(1)

Sprache

Englisch
(125)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Life Sciences & Biomedicine
(84)
Humans
(66)
Neurosciences & Neurology
(65)
Biological And Medical Sciences
(56)
Medical Sciences
(55)
Clinical Neurology
(53)
Pharmacology. Drug Treatments
(35)
Male
(33)
Middle Aged
(28)
Neuropharmacology
(27)
Neurosciences
(27)
Parkinson Disease - Drug Therapy
(26)
Female
(25)
Aged
(24)
Animals
(23)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(20)
Neurology
(18)
Clinical Trials
(15)
Levodopa - Therapeutic Use
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients

An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema

Seeing with new eyes: Finding a path to early intervention trials in Alzheimer’s disease

Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials

Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans

Arrest of Motor Neuron Disease in wobbler Mice Cotreated with CNTF and BDNF

Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function

A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials

Sarcopenia: Biomarkers and imaging (International Conference on Sarcopenia research)

NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients

Trial of Cinpanemab in Early Parkinson’s Disease

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression

Endogenous NGF and CNTF levels in human peripheral nerve injury

Prognostic indicators of survival in ALS

Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease

The Therapeutic Potential of Neurotrophic Factors in the Treatment of Parkinson's Disease

Clinical pharmacokinetics of anti-Parkinsonian drugs

Temporal relationships between plasma and cerebrospinal fluid pharmacokinetics of levodopa and clinical effect in Parkinson's disease

"Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease

Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease

A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis

Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa

Suchergebnisse filtern